Novo Nordisk stops testing of Ozempic as kidney trial meets efficacy goals
HQ Team October 11, 2023: Dutch pharmaceutical company, Novo Nordisk, has stopped testing Ozempic to treat the progression of renal impairment in people.
Drugs
Health
Pharma
Drugs
Health
Pharma
Novo Nordisk, Valo Health sign $2.7 billion pact for drug discovery
HQ Team September 25, 2023: Novo Nordisk and Valo Health, Inc., have signed a $2.7 billion pact to discover and develop novel treatments.
Drugs
Health
Pharma
Novo Nordisk’s weight-loss drug Wegovy enters the UK marketÂ
HQ Team September 4, 2023: Novo Nordisk, a Danish drugmaker, announced its weight-loss medicine, Wegovy, will be available in the UK in a.
Drugs
Health
Pharma
Novo Nordisk to invest $2.3 billion to expand Danish facilityÂ
HQ Team June 13, 2023: Denmark’s Novo Nordisk will invest 15.9 billion kroner ($2.30 billion) to expand its Hillerød production facility in the.
Drugs
Medical
Pharma
Sanofi lowers Lantus insulin costs by 78% in U.S. market
Sanofi, a French pharmaceutical major, announced it would slash the price of insulin, Lantus, by 78% for all U.S. patients with commercial insurance.
Drugs
Pharma
California sues insulin makers, PBMs, for skyrocketing prices
https://oag.ca.gov/news/press-releases/attorney-general-bonta-sues-nations-largest-insulin-makers-pharmacy-benefit